SRE-B Sempra

On June 20, 2023, Sempra (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with BNP Paribas Securities Corp., Goldman Sachs & Co. LLC, MUFG Securities Americas Inc., PNC Capital Markets LLC and RBC Capital Markets, LLC, as the representatives of the several underwriters named on Schedule I thereto (the “Underwriters”), pursuant to which the Company agreed to issue and sell to the Underwriters, severally and not jointly, $550 million aggregate principal amount of its 5.400% Notes due 2026 (the “2026 notes”) and $700 million aggregate principal amount of its 5.500% Notes due 2033 (the “2033 notes”) for resale at a public offering price of (i) in the case of the 2026 notes, 99.627% of the aggregate principal amount of the 2026 notes, and (ii) in the case of the 2033 notes, 99.700% of the aggregate principal amount of the 2033 notes, in each case in a registered public offering under a prospectus supplement and related prospectus filed with the U.S. Securities and Exchange Commission pursuant to the Company’s effective shelf registration statement on Form S-3 (File No. 333-272237). A copy of the Underwriting Agreement is filed as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated herein by reference. The summary set forth above is qualified in its entirety by reference to such exhibit.

This Current Report on Form 8-K does not constitute an offer to sell or the solicitation of an offer to buy any securities nor will there be any sale of these securities in any jurisdiction in which, or to any person to whom, such offer, solicitation or sale would be unlawful. These securities are only offered by means of the prospectus supplement and related prospectus referred to above.